Charis Eng

Dr. Charis Eng is dedicated to advancing knowledge in the field of genetics and genome sciences, with a particular focus on cancer genetics and inherited cancer syndromes. As a Professor and Vice Chair in the Department of Genetics and Genome Sciences at Case Western Reserve University School of Medicine, she plays a pivotal role in shaping the future of genetic research and education. Additionally, she holds a professorship in Molecular Medicine at the Cleveland Clinic Lerner College of Medicine, where she continues to make significant contributions to the understanding of genetic predispositions to cancer. Dr. Eng's research interests are centered around the translational aspects of clinical cancer genetics, with a special emphasis on RET testing in multiple endocrine neoplasia type 2. Her work has been instrumental in broadening the clinical spectra of PTEN mutations, which are crucial in understanding various cancer syndromes. Her research not only aims to identify genes that contribute to inherited cancer susceptibility but also seeks to translate these findings into clinical practice, improving patient outcomes and personalized healthcare strategies. In her role as the founding Director of the Genomic Medicine Institute and the Center for Personalized Genetic Healthcare at the Cleveland Clinic, Dr. Eng has established a robust platform for integrating genomic discoveries into clinical settings. Her leadership in these institutions underscores her commitment to bridging the gap between laboratory research and patient care, ensuring that advancements in genetic research are effectively translated into tangible benefits for patients. Dr. Eng's work is characterized by a deep commitment to interdisciplinary collaboration, bringing together experts from various fields to tackle complex genetic questions. Her efforts have not only advanced the scientific community's understanding of cancer genetics but have also paved the way for innovative approaches to diagnosis and treatment. Her dedication to mentoring the next generation of scientists and clinicians further amplifies her impact, as she inspires and guides emerging leaders in the field. Through her extensive research and leadership roles, Dr. Eng has garnered recognition as a leading authority in the field of genetics and genome sciences. Her contributions have been widely published in prestigious scientific journals, and she is frequently invited to speak at national and international conferences, where she shares her insights and findings with the broader scientific community. Dr. Eng's unwavering dedication to her research and her patients exemplifies her commitment to advancing the field of genetics and improving healthcare outcomes. Her work continues to shape the landscape of personalized medicine, offering hope and solutions to individuals and families affected by genetic disorders and cancer syndromes.